º¸°ÇŸÀÓÁî
HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2025³â 5¿ù 22ÀÏ ¸ñ¿äÀÏ
·Î±×ÀÎÀÌ ÇÊ¿äÇÑ ¼­ºñ½ºÀÔ´Ï´Ù. ·Î±×ÀÎ ÇØÁÖ¼¼¿ä.
BKT´º½º ȸ¿øÀÌ ¾Æ´Ï½Å ºÐÀº ȸ¿ø°¡ÀÔÀ» ÇÏ½Ã¸é Æí¸®ÇÏ°Ô ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
ÀÚµ¿·Î±×ÀÎ
ȸ¿ø°¡ÀÔ ¾ÆÀ̵ð/ºñ¹Ð¹øÈ£Ã£±â
³í¹®) Novel Risk Score for 30-Day Adverse Events..... 2025-05-20
³í¹®) Spironolactone vs Amiloride for Resistant.. 2025-05-20
³í¹®) Predicting Major Adverse Cardiac Events Usin... 2025-05-19
³í¹®) Temporal Trends in Public Stroke Awareness.. 2025-05-16
³í¹®) Lazertinib for patients with NSCLC harboring 2025-05-16
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶
Copyright(c) 2007 BKTIMES.NET All rights Reserved.